Global incidence and prevalence of idiopathic pulmonary fibrosis | Respiratory Research | Full Text
Key recommendations on pharmacological treatment of IPF according to... | Download Table
Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses | Scientific Reports
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
Pleuroparenchymal fibroelastosis in idiopathic pulmonary fibrosis: Survival analysis using visual and computer-based computed tomography assessment - eClinicalMedicine
Drug Interactions With Interstitial Lung Disease Pharmacotherapy
Comparison of recommendations in the 2015 and 2011 idiopathic pulmonary... | Download Table
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: Executive Summary
Summary of finding form Pirfenidone for idiopathic pulmonary fibrosis. | Download Table
Idiopathic pulmonary fibrosis associated with circulating autoantibodies: a Chinese cohort of a long-term follow-up study | Chinese Medical Journal
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study - The Lancet Respiratory Medicine
Systematic review of content and quality of idiopathic pulmonary fibrosis review articles | European Respiratory Society
National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care | BMJ Open Respiratory Research
Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar
New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis | Scientific Reports
Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease – analysis of institutional and population data | Respiratory Research | Full Text
Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients | Scientific Reports
Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry - Respiratory Medicine
Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial - Clinical Nutrition ESPEN
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review | European Respiratory Society
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland - Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem,
Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohort - The Lancet Digital Health
Table 1 from Idiopathic Pulmonary Fibrosis. | Semantic Scholar
Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study | BMC Pulmonary Medicine | Full Text
Frontiers | Road Toward a New Model of Care for Idiopathic Pulmonary Fibrosis in the Lazio Region
